Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice.
暂无分享,去创建一个
B. Wilhelm | K. Tung | J. Landry | A. Makrigiannis | L. Tai | D. Raulet | A. Mahmoud | Qinzhang Zhu | M. Tu | M. Rahim | Rajen Patel | S. Bélanger | Angela D. Troke
[1] S. Jonjić,et al. Distinct MHC class I–dependent NK cell–activating receptors control cytomegalovirus infection in different mouse strains , 2011, The Journal of experimental medicine.
[2] A. Makrigiannis,et al. Effect of Ly49 Haplotype Variance on NK Cell Function and Education , 2010, The Journal of Immunology.
[3] L. Lanier,et al. Natural killer cells in NOD.NK1.1 mice acquire cytolytic function during viral infection and provide protection against cytomegalovirus , 2010, Proceedings of the National Academy of Sciences.
[4] S. Jonjić,et al. Intact NKG2D-Independent Function of NK Cells Chronically Stimulated with the NKG2D Ligand Rae-1 , 2010, The Journal of Immunology.
[5] L. Lanier,et al. “Unlicensed” Natural Killer cells dominate the response to cytomegalovirus infection , 2010, Nature Immunology.
[6] Sofia Johansson,et al. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. , 2009, Blood.
[7] A. Makrigiannis,et al. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC , 2008, The Journal of experimental medicine.
[8] A. Makrigiannis,et al. Evolution of the Ly49 and Nkrp1 recognition systems. , 2008, Seminars in immunology.
[9] S. Anderson,et al. Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome , 2008, Genes and Immunity.
[10] A. Shilatifard,et al. The A, B, Gs of silencing. , 2007, Genes & development.
[11] G. Leclercq,et al. Interactions of Ly49 Family Receptors with MHC Class I Ligands in trans and cis1 , 2007, The Journal of Immunology.
[12] J. Orange. Human natural killer cell deficiencies , 2006, Current opinion in allergy and clinical immunology.
[13] R. Vance,et al. Self-tolerance of natural killer cells , 2006, Nature Reviews Immunology.
[14] L. Lybarger,et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.
[15] R. Vance,et al. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. , 2005, Blood.
[16] F. Lemonnier,et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules , 2005, The Journal of experimental medicine.
[17] K. Dewar,et al. Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes , 2005, Genes and Immunity.
[18] J. Ryan,et al. Molecular cloning of KLRI1 and KLRI2, a novel pair of lectin-like natural killer-cell receptors with opposing signalling motifs , 2005, Immunogenetics.
[19] S. Lockett,et al. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. , 2004, Immunity.
[20] D. Cado,et al. Genomic Ly49A Transgenes: Basis of Variegated Ly49A Gene Expression and Identification of a Critical Regulatory Element1 , 2004, The Journal of Immunology.
[21] M. Smyth,et al. Blastocyst MHC, a Putative Murine Homologue of HLA-G, Protects TAP-Deficient Tumor Cells from Natural Killer Cell-Mediated Rejection In Vivo1 , 2003, The Journal of Immunology.
[22] S. Anderson,et al. A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. , 2002, Genomics.
[23] E. Chiang,et al. The Nonclassical Major Histocompatibility Complex Molecule Qa-2 Protects Tumor Cells from NK Cell- and Lymphokine-Activated Killer Cell-Mediated Cytolysis1 , 2002, The Journal of Immunology.
[24] N. Shastri,et al. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages , 2000, Nature Immunology.
[25] H. Ljunggren,et al. Role of Qa‐1b‐binding receptors in the specificity of developing NK cells , 2000, European journal of immunology.
[26] T. Hanke,et al. NK cell expression of the killer cell lectin‐like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules , 2000, European journal of immunology.
[27] J. Schatzle,et al. Ly49I NK Cell Receptor Transgene Inhibition of Rejection of H2b Mouse Bone Marrow Transplants1 2 , 2000, The Journal of Immunology.
[28] D. Busch,et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. , 1999, Immunity.
[29] M. Kronenberg,et al. The Murine Nonclassical Class I Major Histocompatibility Complex–like CD1.1 Molecule Protects Target Cells from Lymphokine-activated Killer Cell Cytolysis , 1999, The Journal of experimental medicine.
[30] J. Altman,et al. Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b , 1998, The Journal of experimental medicine.
[31] J. Dorfman,et al. The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice. , 1997, Journal of Immunology.
[32] D. Raulet,et al. Ly49A Transgenic Mice Provide Evidence for a Major Histocompatibility Complex–dependent Education Process in Natural Killer Cell Development , 1997, The Journal of experimental medicine.
[33] T. Ley,et al. Long-range disruption of gene expression by a selectable marker cassette. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] R. Jaenisch,et al. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. , 1991, Science.
[35] J L Sullivan,et al. Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.
[36] H. Ljunggren,et al. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.
[37] G. Klein,et al. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. , 1985, Journal of immunology.
[38] A. Makrigiannis,et al. Molecular and Genetic Basis for Strain-Dependent NK1.1 Alloreactivity of Mouse NK Cells , 2006 .